
ClearPoint Neuro CLPT
€ 9.35
-2.5%
Geschäftsbericht 2025
hinzugefügt 17.03.2026
ClearPoint Neuro Betriebsaufwand 2011-2026 | CLPT
Betriebsaufwand Jährlich ClearPoint Neuro
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 15.3 M | 12 M | 10.2 M | 10.8 M | 10.6 M | 10.3 M | 11.3 M | 9.98 M | 7.63 M | 9.08 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 15.3 M | 7.63 M | 10.7 M |
Betriebsaufwand anderer Aktien in der Medizinische Geräte
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Globus Medical
GMED
|
547 M | $ 91.77 | -2.06 % | $ 12.4 B | ||
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 13.29 | 1.57 % | $ 1.8 B | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
Electromed
ELMD
|
40.3 M | $ 26.02 | 0.08 % | $ 220 M | ||
|
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.22 | -0.41 % | $ 121 M | ||
|
LENSAR
LNSR
|
32.6 M | $ 5.41 | 3.84 % | $ 64.7 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.64 | 4.58 % | $ 39.8 M | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Orthofix Medical
OFIX
|
344 M | $ 12.13 | -1.54 % | $ 480 M | ||
|
PAVmed
PAVM
|
54.3 M | $ 8.54 | 1.67 % | $ 5.73 M | ||
|
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.09 | -1.42 % | $ 1.27 M | ||
|
Eargo
EAR
|
126 M | - | - | $ 10.2 M | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
Sintx Technologies
SINT
|
11.2 M | $ 2.36 | 0.43 % | $ 6.55 M | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
Stryker Corporation
SYK
|
11.2 B | $ 322.76 | -1.9 % | $ 123 B | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Tactile Systems Technology
TCMD
|
221 M | $ 23.28 | -3.96 % | $ 532 M | ||
|
TELA Bio
TELA
|
88.1 M | $ 0.79 | -1.53 % | $ 37.1 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
LivaNova PLC
LIVN
|
697 M | $ 61.14 | -3.59 % | $ 3.34 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
TransMedics Group
TMDX
|
254 M | $ 101.84 | -5.81 % | $ 3.46 B | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
Tandem Diabetes Care
TNDM
|
159 M | $ 18.95 | -4.36 % | $ 1.29 B | ||
|
Pulmonx Corporation
LUNG
|
121 M | $ 1.23 | -4.3 % | $ 50 M | ||
|
Butterfly Network
BFLY
|
123 M | $ 5.27 | -3.92 % | $ 1.12 B | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.43 | -2.47 % | $ 362 M | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 10.76 | -0.74 % | $ 385 M | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.04 | -3.7 % | $ 17.6 M | ||
|
CONMED Corporation
CNMD
|
648 M | $ 36.87 | -2.64 % | $ 1.14 B | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 54.99 | -0.15 % | $ 1.61 B | ||
|
Integer Holdings Corporation
ITGR
|
279 M | $ 84.36 | -1.16 % | $ 2.93 B | ||
|
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M |